Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 8 de 8
Filter
Add more filters










Database
Language
Publication year range
1.
J Biol Chem ; 271(49): 31367-71, 1996 Dec 06.
Article in English | MEDLINE | ID: mdl-8940144

ABSTRACT

Apolipoprotein(a) (apo(a)), the distinguishing protein of atherogenic lipoprotein(a), directs accumulation of the lipoprotein(a) particle to sites in the arterial wall where atherosclerotic lipid lesions develop in man and in transgenic mice expressing human apo(a). It has been proposed that focal apo(a) accumulation in the transgenic mouse vessel wall causes the observed severe local inhibition of transforming growth factor-beta (TGF-beta) activity and the consequent activation of the smooth muscle cells, which subsequently accumulate lipid to form lesions if the mice are fed a high fat diet. We show that blocking formation of these vascular lesions by two independent mechanisms, tamoxifen treatment and increasing high density lipoprotein, also abolishes apo(a) accumulation, inhibition of TGF-beta activity, and activation of smooth muscle cells. The data are consistent with a feedback mechanism in which an initial accumulation of apo(a) inhibits local TGF-beta activity, leading to further accumulation of apo(a). Breaking the feedback loop prevents smooth muscle cell activation and therefore lipid lesion development.


Subject(s)
Apolipoproteins A/metabolism , Muscle, Smooth, Vascular/metabolism , Transforming Growth Factor beta/metabolism , Animals , Apolipoprotein A-I/metabolism , Cell Differentiation , Dietary Fats/adverse effects , Humans , Lipoproteins, HDL/metabolism , Male , Mice , Mice, Transgenic , Microscopy, Electron , Muscle, Smooth, Vascular/ultrastructure , Tamoxifen/pharmacology
2.
J Immunol Methods ; 152(1): 105-13, 1992 Jul 31.
Article in English | MEDLINE | ID: mdl-1640105

ABSTRACT

Antibody responses and health parameters were compared in rabbits immunized with a synthetic polypeptide antigen, [L-Tyr,L-Glu,DL-Ala]-poly-L-lysine ((TG)-AL), in Freund's (FA) or Ribi (RA) adjuvants. Rabbits, 12 weeks old, of both sexes, were inoculated with 0.5 ml divided between two intramuscular (i.m.) sites. Eight received FA and antigen (50 micrograms); eight RA and antigen, eight PBS and antigen; four FA and PBS; four RA and PBS, and four PBS. Identical booster inoculations were made 21 days later, except that incomplete FA was substituted for complete FA. Rabbits were monitored until euthanasia and necropsy 7 weeks after the primary inoculation. Sera, obtained weekly, were analyzed for immunoglobulins using an enzyme immunoassay. Only rabbits given antigen with adjuvant produced high titered antibodies. Mean optical density values for immunoglobulin (Ig)M were greater the week after the booster in the group given FA. IgG values were similar for both adjuvant/antigen groups the week after the booster, but thereafter decreased in rabbits given RA. Antisera from rabbits given antigen with FA had greater avidity for the antigen than that from rabbits given antigen with RA, however, the difference was not significant (p greater than 0.05). Rabbits inoculated with FA and antigen had high serum creatinine kinase levels the day after inoculation, showed evidence of discomfort, and extensive granulomatous inflammation at the inoculation sites. Lesions were minimal to mild in rabbits given antigen with RA and PBS with either adjuvant. While RA did not result in adverse side effects, the IgG response to (TG)-AL with RA was transient compared to FA.


Subject(s)
Antibody Formation , Cell Wall Skeleton , Cord Factors/administration & dosage , Freund's Adjuvant/administration & dosage , Lipid A/analogs & derivatives , Peptides/immunology , Animals , Cord Factors/adverse effects , Creatine Kinase/blood , Female , Freund's Adjuvant/adverse effects , Immunoglobulin G/biosynthesis , Immunoglobulin G/blood , Immunoglobulin M/biosynthesis , Immunoglobulin M/blood , Injections, Intramuscular , Leukocyte Count , Lipid A/administration & dosage , Lipid A/adverse effects , Male , Peptides/adverse effects , Rabbits , Respiration/immunology
3.
Bioelectromagnetics ; 13(6): 469-96, 1992.
Article in English | MEDLINE | ID: mdl-1482413

ABSTRACT

Our goal was to investigate effects of long-term exposure to pulsed microwave radiation. The major emphasis was to expose a large sample of experimental animals throughout their lifetimes and to monitor them for effects on general health and longevity. An exposure facility was developed that enabled 200 rats to be maintained under specific-pathogen-free (SPF) conditions while housed individually in circularly-polarized waveguides. The exposure facility consisted of two rooms, each containing 50 active waveguides and 50 waveguides for sham (control) exposures. The experimental rats were exposed to 2,450-MHz pulsed microwaves at 800 pps with a 10-microseconds pulse width. The pulsed microwaves were square-wave modulated at 8-Hz. Whole body calorimetry, thermographic analysis, and power-meter analysis indicated that microwaves delivered at 0.144 W to each exposure waveguide resulted in an average specific absorption rate (SAR) that ranged from 0.4 W/kg for a 200-g rat to 0.15 W/kg for an 800-g rat. Two hundred male, Sprague-Dawley rats were assigned in equal numbers to radiation-exposure and sham-exposure conditions. Exposure began at 8 weeks of age and continued daily, 21.5 h/day, for 25 months. Animals were bled at regular intervals and blood samples were analyzed for serum chemistries, hematological values, protein electrophoretic patterns, thyroxine, and plasma corticosterone levels. In addition to daily measures of body mass, food and water consumption by all animals, O2 consumption and CO2 production were periodically measured in a sub-sample (N = 18) of each group. Activity was assessed in an open-field apparatus at regular intervals throughout the study. After 13 months, 10 rats from each group were euthanatized to test for immunological competence and to permit whole-body analysis, as well as gross and histopathological examinations. At the end of 25 months, the survivors (11 sham-exposed and 12 radiation-exposed rats) were euthanatized for similar analyses. The other 157 animals were examined histopathologically when they died spontaneously or were terminated in extremis.


Subject(s)
Microwaves , Animals , Behavior, Animal/radiation effects , Blood Chemical Analysis , Body Weight/radiation effects , Corticosterone/blood , Immunity/radiation effects , Longevity/radiation effects , Male , Neoplasms, Radiation-Induced/etiology , Radiation Dosage , Rats , Rats, Sprague-Dawley , Time Factors
4.
Cancer Res ; 51(2): 676-81, 1991 Jan 15.
Article in English | MEDLINE | ID: mdl-1845957

ABSTRACT

A 186Re-labeled monoclonal antibody (MAb), NR-LU-10, was used for the radioimmunotherapy of a subcutaneous human small cell lung carcinoma xenograft, SHT-1, in nude mice. Biodistribution with specific and irrelevant labeled MAb demonstrated peak tumor uptake of 8% and 3% of the injected dose/g at 2 days, respectively. Dosimetry analysis predicted tumor:whole-body radiation-absorbed dose ratios of 2.43:1 for NR-LU-10 and 0.62:1 for irrelevant MAb. Single-dose toxicity screening estimated a 50% lethal dose within 30 days of 600 microCi (880 cGy of whole-body radiation). As anticipated, a multiple-dose regimen of 490 microCi in four doses over 10 days (720 cGy of whole-body radiation, eight of eight surviving greater than 30 days) was less toxic than a single bolus dose of 430 microCi (644 cGy of whole-body radiation), six of eight surviving greater than 30 days). A multidose radioimmunotherapy regimen was initiated in nude mice bearing 66-mm3 tumors (total dose, 500 to 600 microCi). Complete remissions (greater than 140 days) were achieved in three of 16 mice, and the remainder showed a mean tumor growth delay of 53 days. Matched doses with irrelevant MAb produced one remission, one treatment-related death, and a mean growth delay of only 20 days in six of eight mice. Thus, in this nonoptimal radioimmunotherapy model, significant antitumor responses were observed using a mildly toxic multiple dosing regimen.


Subject(s)
Antibodies, Monoclonal/therapeutic use , Carcinoma, Small Cell/therapy , Lung Neoplasms/therapy , Radioisotopes/therapeutic use , Rhenium/therapeutic use , Animals , Autoradiography , Carcinoma, Small Cell/pathology , Carcinoma, Small Cell/radiotherapy , Cell Line , Female , Humans , Immunotherapy , Lung Neoplasms/pathology , Lung Neoplasms/radiotherapy , Mice , Mice, Nude , Neoplasm Transplantation , Rhenium/pharmacokinetics , Tissue Distribution , Transplantation, Heterologous
6.
AJR Am J Roentgenol ; 147(3): 627-31, 1986 Sep.
Article in English | MEDLINE | ID: mdl-3488665

ABSTRACT

A toxicologic-pathologic study of isobutyl-2-cyanoacrylate (Bucrylate) was carried out first in dogs and then in humans whose arteriovenous malformations were infused with this embolic agent. The canine specimens obtained at 7, 18, 28, and 147 days after embolization showed the development of a mild histiocytic giant cell reaction, which evolved to end-state sclerotic arteritis. The response was confined to the vessels and did not involve contiguous parenchymal tissues. Ten human specimens, obtained from 1 hr to 7 years after treatment, showed a similar bland reaction with no evidence of suppuration or premalignant changes.


Subject(s)
Arteries/drug effects , Bucrylate/pharmacology , Cerebral Arteries/drug effects , Cyanoacrylates/pharmacology , Embolization, Therapeutic , Iodobenzenes/pharmacology , Iophendylate/pharmacology , Adolescent , Adult , Animals , Arteries/pathology , Brain/drug effects , Brain/pathology , Bucrylate/administration & dosage , Cerebral Arteries/pathology , Dogs , Female , Humans , Intracranial Arteriovenous Malformations/pathology , Intracranial Arteriovenous Malformations/therapy , Iophendylate/administration & dosage , Male , Middle Aged , Renal Artery/drug effects , Renal Artery/pathology , Time Factors
7.
Am J Pathol ; 111(2): 224-33, 1983 May.
Article in English | MEDLINE | ID: mdl-6846503

ABSTRACT

Clinical and pathologic features of cyclic hematopoiesis in 18 grey collie dogs, aged 10 to 113 weeks, were reviewed. The dogs were grouped according to weeks of age: 10-16 (I), 17-21 (II), 30-35 (III), and less than 52 (IV). Clinical illness occurring during each hematopoietic cycle was classified as none, mild, moderate, or severe, based on the neutrophil count, rectal temperature, clinical signs, and use of antimicrobial therapy. The dogs in Groups I, III, and IV had severe infections episodes during one-fourth of all hematopoietic cycles; whereas the dogs in Group II had severe infections during two-thirds of cycles. However, during the cycle prior to death, all groups were similar, each having two-thirds of clinical syndromes classified as severe and one-third as mild. More dogs died during the neutropenic phase of the hematopoietic cycle than during the nonneutropenic phase. Pathologic findings showed distinct patterns in relation to age. Younger dogs showed evidence of acute infectious processes, especially in the lungs, gastrointestinal tract, and kidneys; whereas older dogs had chronic inflammatory changes in those organs. Amyloidosis was a prominent finding in dogs over 30 weeks of age. These findings indicate that predictable age-related changes in tissues of grey collie dogs impair various organ systems and thereby contribute to morbidity and mortality in older dogs. consequently, future clinical and pathologic studies of grey collies should take into consideration the age of the dogs under study.


Subject(s)
Agranulocytosis/veterinary , Dog Diseases/pathology , Hematopoiesis , Neutropenia/veterinary , Animals , Digestive System/pathology , Dogs , Infections/etiology , Kidney/pathology , Leukocyte Count , Liver/pathology , Lung/pathology , Lymph Nodes/pathology , Myocardium/pathology , Neutropenia/complications , Neutropenia/pathology , Neutrophils , Spleen/pathology
8.
Bioelectromagnetics ; 4(1): 63-77, 1983.
Article in English | MEDLINE | ID: mdl-6838668

ABSTRACT

Two groups of 16 male New Zealand rabbits were exposed to 2450-MHz continuous wave microwave fields in two experiments of 90 days each. The incident power densities of the first and second experiment were 0.5 and 5 mW/cm2, respectively. During each study, 16 animals were adapted to a miniature anechoic chamber exposure system for at least 2 weeks, then 8 of them were exposed for 7 h daily, 5 days a week for 13 weeks, and the other 8 animals were sham exposed. The rabbits were placed in acrylic cages, and each was exposed from the top in an individual miniature anechoic chamber. Thermography showed a maximum specific absorption rate of 5.5 W/kg in the head and 7 W/kg in the back at 5-mW/cm2 incident power density. After each 7-h exposure session, the animals were returned to their home cages. Food consumption in the exposure chamber and body mass were measured daily. Blood samples were taken before exposure and monthly thereafter for hematological, morphological, chemical, protein electrophoresis, and lymphocyte blast transformation studies. Eyes were examined for cataract formation. Finally, pathological examinations of 28 specimens of organs and tissues of each rabbit were performed. Statistically, there was a significant (P less than .01) decrease only of food consumption during the 5-mW/cm2 exposure; other variables were not significantly different between exposed and control groups.


Subject(s)
Microwaves , Rabbits/physiology , Animals , Blood/radiation effects , Blood Proteins/radiation effects , Body Weight/radiation effects , Eating/radiation effects , Electrophoresis , Eye/radiation effects , Hematologic Tests , Lymphocytes/radiation effects , Male , Rabbits/blood
SELECTION OF CITATIONS
SEARCH DETAIL
...